Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Pfizer PFE and AstraZeneca AZN are two global pharmaceutical leaders with a commanding presence in oncology. For Pfizer, oncology is a key growth driver, accounting for roughly 27% of total company ...
Hosted on MSN
AstraZeneca targets $400B Bristol Myers Squibb merger twelve years after spurning Pfizer
AstraZeneca — the British pharmaceutical giant that famously rebuffed a $118 billion hostile takeover from Pfizer in 2014 by pledging to remain fiercely independent — is now reportedly pursuing a ...
Investor's Business Daily on MSN
AstraZeneca digs $2 billion out of its coffers for Summit deal, taking on Bristol, Pfizer, Merck
Summit Therapeutics stock jumped Tuesday after AstraZeneca made a $2 billion investment in the smaller biotech.
AstraZeneca (LSE:AZN) has launched a new AI-driven biologics discovery collaboration with Carterra, announced ahead of ...
WASHINGTON, July 9 (Reuters) - A U.S. appeals court on Thursday upheld a ruling for AstraZeneca (AZN.L), opens new tab against allegations that its blockbuster lung-cancer drug Tagrisso infringed ...
AstraZeneca’s breast cancer pill camizestrant (Etcamah) failed to improve progression-free survival in a late-stage trial when added to standard therapy, despite an earlier ESR1 mutation–targeted ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results